Skip to main navigation Skip to search Skip to main content

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.'. Together they form a unique fingerprint.
Sort by

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science